Old Web
English
Sign In
Acemap
>
authorDetail
>
Hanne Oestergaard Larsen
Hanne Oestergaard Larsen
Aarhus University Hospital
Myeloid
Immunology
Medicine
CD34
Minimal residual disease
5
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia.
2014
British Journal of Haematology
Anne Stidsholt Roug
Hanne Oestergaard Larsen
Line Nederby
Tom Just
Gordon D. Brown
Charlotte Guldborg Nyvold
Hans Beier Ommen
Peter Hokland
Show All
Source
Cite
Save
Citations (40)
Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
2012
Cytometry Part B-clinical Cytometry
Hanne Oestergaard Larsen
Anne Stidsholt Roug
Tom Just
Gordon D. Brown
Peter Hokland
Show All
Source
Cite
Save
Citations (43)
Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?
2011
Blood
Anne Stidsholt Roug
Hanne Oestergaard Larsen
Hans Beier Ommen
Peter Hokland
Show All
Source
Cite
Save
Citations (0)
CD34+ SSCloALDHbr – a New Marker for Improved Characterization of Poor Myeloid Regeneration in the Autologous Hematopoietic Transplantation Setting?,
2011
Blood
Katrine Nielsen
Lea Bjerre
Hanne Oestergaard Larsen
Peter Hokland
Anne Stidsholt Roug
Show All
Source
Cite
Save
Citations (0)
1